Home › Employers › Kaiser Biotech, Inc.
Kaiser Biotech, Inc.: H-1B salaries and sponsorship
Kaiser Biotech, Inc. filed 4 labor condition applications for H-1B and related visas in fiscal years 2023–2026; certified: 4. Median offered salary: $90,040.
Does Kaiser Biotech, Inc. sponsor H-1B visas?
Kaiser Biotech, Inc. filed 4 labor condition applications in fiscal years 2023–2026, the latest submitted on Mar 3, 2025. An LCA is the first step of an H-1B petition, so the employer has sponsored or prepared to sponsor H-1B workers; it does not guarantee sponsorship for any particular job. Check the employer's own job listings.
Salaries by job title
| Job title | LCAs | Median salary |
|---|---|---|
| Senior Strategic Management Analyst | 1 | $150,000 |
| Data Scientist | 1 | $100,000 |
| Accountant | 1 | $60,000 |
| Managerial Economist | 1 | $80,080 |
Applications by fiscal year
| Fiscal year | LCAs | Median salary |
|---|---|---|
| FY2023 | 3 | $100,000 |
| FY2025 | 1 | $80,080 |
Prevailing wage levels
The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.
Where the jobs are
Occupations
Latest applications
| Job title | Base salary | Location | Submitted | Start date | Status |
|---|---|---|---|---|---|
| Managerial Economist | $80,080 Level II | Sacramento, CA | Mar 3, 2025 | Sep 2, 2025 | Certified |
| Senior Strategic Management Analyst | $150,000 Level IV | Sacramento, CA | Mar 15, 2023 | Sep 8, 2023 | Certified |
| Data Scientist | $100,000 Level II | Revere, MA | Mar 14, 2023 | Sep 8, 2023 | Certified |
| Accountant | $60,000 Level II | Urbana, IL | Mar 10, 2023 | Sep 8, 2023 | Certified |
Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).